It's a positive step that Pfizer are still continung to evaluate the candidates & a milestone has been triggered, I'd go out an a limb & say another $500K payment. I guess we will be able to see come the quarterly report end of July.
Big news will be when/if Pfizer take out a commercial license on a candidate with a milestone then triggered in the $2M range thats when a licensing agreement will be formalised & we can start looking at toxicity & proof of concept studies triggering further milestones before eventually moving into the clinic with Phase I studies - it's a long road ahead but we are ticking boxes.
It's a positive step that Pfizer are still continung to evaluate...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.030(2.21%) |
Mkt cap ! $810.7M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.39 | $1.33 | $103.4K | 75.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2600 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |